Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Inventory (2017 - 2025)

Historic Inventory for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q2 2025 value amounting to $553000.0.

  • CollPlant Biotechnologies' Inventory rose 2596.81% to $553000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $553000.0, marking a year-over-year increase of 2596.81%. This contributed to the annual value of $440000.0 for FY2024, which is 3837.54% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Inventory of $553000.0 as of Q2 2025, which was up 2596.81% from $673.0 million recorded in Q1 2025.
  • CollPlant Biotechnologies' Inventory's 5-year high stood at $1081.0 billion during Q4 2021, with a 5-year trough of $439000.0 in Q2 2024.
  • In the last 5 years, CollPlant Biotechnologies' Inventory had a median value of $1.5 million in 2022 and averaged $60.4 billion.
  • As far as peak fluctuations go, CollPlant Biotechnologies' Inventory soared by 8565758621.24% in 2021, and later crashed by 9995.01% in 2023.
  • Over the past 5 years, CollPlant Biotechnologies' Inventory (Quarter) stood at $1081.0 billion in 2021, then crashed by 99.87% to $1.4 billion in 2022, then tumbled by 99.95% to $714000.0 in 2023, then plummeted by 38.38% to $440000.0 in 2024, then increased by 25.68% to $553000.0 in 2025.
  • Its Inventory stands at $553000.0 for Q2 2025, versus $673.0 million for Q1 2025 and $440000.0 for Q4 2024.